1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Macular Pucker: new trials by email Literature Review of Macular Pucker trials Research Report on Macular Pucker
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Topical Nepafenac After Epiretinal Membrane Surgery Nepafenac 0.1% Ophthalmic Suspension, Pars Plana Vitrectomy With Epiretinal Membrane and Internal Limiting Membrane Peeling - Epiretinal Membrane, Macular Pucker | Phase 4 | Completed | Ankara Yildirim Beyazıt University | 60 | 2024-01-01 | 2026-07-30 |
| Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. Dexamethasone Intracanalicular Insert, 0.4 mg, Prednisone acetate 1% - Vitrectomy, Macular Pucker | Phase 4 | Unknown | Kovach Eye Institute | 60 | 2021-04-27 | 2023-06-29 |
Epiretinal Membrane (2) · Papilledema (1)
Eye Diseases (2) · Retinal Diseases (2) · Cranial Nerve Diseases (1) · Nervous System Diseases (1) · Optic Nerve Diseases (1)
nepafenac (1)
Ankara Yildirim Beyazıt University (1) · Kovach Eye Institute (1)
Turkey (Türkiye) (1) · United States (1)
Saad Ahmad, MD (1)